NATO - STANAG 2242
POLICY FOR THE CHEMOPROPHYLAXIS AND IMMUNOTHERAPY OF NATO PERSONNEL AGAINST BIOLOGICAL WARFARE AGENTS
active, Most Current
| Organization: | NATO |
| Publication Date: | 10 May 2005 |
| Status: | active |
| Page Count: | 10 |
scope:
The aim of this agreement is to develop a unified approach in NATO doctrine and policy in the use of chemoprophylaxis and immunotherapy by NATO personnel against Biological Warfare (BW) agents that cause infectious disease.
Document History
STANAG 2242
May 10, 2005
POLICY FOR THE CHEMOPROPHYLAXIS AND IMMUNOTHERAPY OF NATO PERSONNEL AGAINST BIOLOGICAL WARFARE AGENTS
The aim of this agreement is to develop a unified approach in NATO doctrine and policy in the use of chemoprophylaxis and immunotherapy by NATO personnel against Biological Warfare (BW) agents that...